SUMMARY Cerebrovascular responses to hemorrhage induced hypotension were tested in aged (24 month) spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto (WKY) after ten weeks of antihypertensive drug or sham treatment. Antihypertensive drug treatment consisted of 1 mg/kg/day minoxidil, 4 mg/kg/day hydralazine and 4 mg/kg/day propranolol given in the drinking water. Antihyper tensive therapy produced a 30% decrease in systolic blood pressure in aged SHR to levels not significantly different from sham treated WKY. Cerebral blood flow (CBF), measured under control conditions using ketamine anesthesia, was not significantly different between sham and drug treated SHR and WKY. Cerebral oxygen metabolic rate (CMR02) was significantly decreased in drug treated SHR and WKY compared to sham treated rats. Lowering blood pressure to a level between 80 and 95 torr produced no significant change in CBF or CMR02 in sham or drug treated WKY or antihypertensive treated SHR, but a produced a significant decrease in both CBF and CMR02 in sham treated SHR. Decreasing mean blood pressure to 50-60 torr produced a significant decrease in CBF but not CMR02 in both WKY treatment groups and in antihypertensive treated SHR, but again in sham treated SHR both CBF and CMR02 were significantly decreased. These results indicate that aged hypertensive rats are unable to maintain CBF or CMR02 under even moderate hypotensive test conditions, but that cerebral autoregulation can be im proved with antihypertensive therapy.
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Stroke, Vol 13, No 5, 1982 STUDIES HAVE SHOWN that chronic hypertension trolled oven for pressure measurement. SHR and produces cerebrovascular changes which produce a WKY receiving antihypertensive therapy were given shift in cerebral autoregulation and inhibit the ability of the following drugs: minoxidil (1 mg/kg/day), hydral hypertensive subjects to maintain cerebral blood flow azine (4 mg/kg/day), propranolol (4 mg/kg/day). The (CBF) and cerebral oxygen metabolism (CMR02) drugs were added to the drinking water with the con during hypotensive stimuli. [1] [2] [3] [4] [5] This problem may be centration adjusted to the daily intake of the rat. Four increased in the aged hypertensive subject due to struc test groups were chosen with 15-20 rats per group. tural vascular changes such as atherosclerosis develop SHR and WKY received either ten weeks of antihyper ment, increased collagen formation, intimal fibrinotensive drug or sham (water) treatment. Initiation of hyalin incorporation and loss of vascular elasticity. [6] [7] [8] [9] treatment was staggered so that an equal number of rats This is supported by reports that maintenance of CBF from each group completed the treatment regimen and and CMR02 during hypotension is complicted by ag could be tested each week. ing and hypertension.
1 ' 10, " Little is known concerning the effect of antihypertensive therapy on cerebral au Surgery toregulation in aged hypertensive subjects. It is impor At the end of the ten week drug or sham treatment tant to determine whether antihypertensive drug treat period, rats from each test group were prepared for ment can improve cerebrovascular performance in microsphere test procedures. Rats received a constant aged subjects in which hypertension has been main iv infusion of 0.13 mg/kg/min ketamine during the tained chronically for prolonged periods. In these ex surgical and test procedures using a Harvard infusion/ periments we have tested the effect of ten weeks of withdrawal pump. Each rat received 0.1 mg/kg tubo antihypertensive therapy on cerebral autoregulation every 30 minutes. A tracheostomy per curare was and the ability to maintain CMR02 during hemorrhage formed and the rat was artificially ventilated with 30% induced hypotension in aged SHR and Wistar Kyoto oxygen and 70% room air using a Harvard small ani rats (WKY). mal respirator. PE50 tubing catheters, filled with hepa rinized isotonic saline were inserted into both femoral Methods arteries and both femoral veins and into the left ventri Antihypertensive Drug Treatment cle via the right carotid artery. Pressure pulses were Twenty-four month old male retired breeder sponta monitored to ensure proper placement of the ventricu neously hypertensive rats (SHR) and Wistar Kyoto lar catheter. Following the completion of this surgery controls (WKY) (Charles Rivers Inc.) were used in all incisions were closed using wound clips and the rat these experiments. Systolic blood pressure was meas was placed on a stereotaxic head holder. The skull was ured indirectly 1-2 times per week in these rats using exposed, the bone over the sagittal sinus drilled away the tail cuff occlusion apparatus of Narco Biosystems.
and a 23 gauge needle inserted into the sinus stereotaxRats were warmed to 32C using a temperature conically to be used for drawing blood samples. Following the completion of all surgical procedures the rat was maintained at 37C with the aid of overhead heat lamps. Mean blood pressure was continuously recorded from a femoral artery catheter.
Microspheres
Microsphere tests were performed using a modifica tion of previously described methods.
n Tests were per formed randomly in all four test groups under each of 3 test conditions: 1) control -baseline blood pressure, 2) mid-pressure -each rat was hemorrhaged to a mean pressure level of 85-90 torr, 3) low-pressurehemorrhage induced hypotension to a pressure level of 55-60 torr. At least 15 minutes were allowed between each test.
Before each microsphere injection the pressure pulses of the left ventricular catheter were monitored to ensure catheter placement. Three separate labelled mi crospheres were used, cobalt-57, ruthenium-103 and scandium-46 (New England Nuclear). Stock solutions containing 500,000 15>u. microspheres/ml were sus pended in isotonic saline with 0.01% Tween-80. Mi crosphere samples were vortexed for one minute, an 0.2 ml sample withdrawn, injected into the left ventri cle and flushed in with 0.2 ml saline over a 20 second period. Starting immediately before each injection and continuing 45 seconds after the end of the microsphere injection, blood was withdrawn from both femoral ar tery catheters at a rate of 0.4 ml/min using a 2 channel Harvard infusion/withdrawal pump. Arterial blood gas measurements were taken at the end of each micro sphere test. Arterial and sagittal sinus blood samples were also taken after each microsphere test for meas urement of cerebral arterial-venous oxygen content. Pressure was maintained at each respective pressure level throughout the testing procedure. At the end of the third or final microsphere test the rat was sacri ficed, the brain removed, weighed and stored in 10% formalin overnight. The following day the brain was blotted dry and placed in counting vials. The activity of each microsphere label in brain and blood samples was analyzed using a Nuclear Chicago 1035 gamma counter and Nuclear Data 600 multi-channel analyzer. CBF was analyzed according to the methods of Hey mann et al. 13 using an Inerdata computer. Oxygen con tent of blood was analyzed using an Instrumentation Laboratory co-oximeter. CMR02 was calculated by multiplying CBF, corrected for brain weight, by cere bral arterial-venous oxygen content. Preliminary tests indicated that 3 repeated control microsphere tests in the same rat produced reproducable measures of CBF and CMR02 under the same experimental conditions as used here. All data are reported as mean + SE and statistical comparisons wre made with unpaired Mests and a treatment by groups linear model analysis of variance.
Results
The effect of antihypertensive drug treatment on systolic blood pressure is shown in figure 1 . Sham treatment had no significant effect of blood pressure in either SHR or WKY over the ten week treatment peri od. Antihypertensive drug treatment produced a de crease in blood pressure in both SHR and WKY. Blood pressure decreased for approximately four weeks and was maintained at this level for the remainder of the ten week treatment period. Blood pressure decreased sig nificantly more in SHR during antihypertensive drug treatment than in WKY (p < .05). Blood pressure,* heart rate and blood gas changes under control anesthe tized conditions and during hemorrhage induced hypo tension are shown in table 1. Sham treated SHR were significantly hypertensive under control conditions compared to WKY and to antihypertensive treated SHR (p < .01). Mean blood pressure under control conditions in antihypertensive treated SHR was sig nificantly greater than antihypertensive treated WKY (p < .05) but not sham treated WKY. Arterial PC02 did not vary significantly between treatment groups or over treatment conditions and average arterial P02 was maintained above 100 torr for all tests. The effect of hemorrhage induced hypotension on CBF and CMR02 is shown in figure 2 . Under control condi tions, CBF was not significantly different between any of the test groups. CMR02 was not significantly dif ferent between sham treated SHR and WKY or be tween antihypertensive treated SHR and WKY, but CMR02 was significantly decreased (p < .05) in anti hypertensive compared to sham treated rats. Hemor rhage induced hypotension to a mid-pressure level of 80-95 torr significantly decreased CBF and CMR02 only in sham treated SHR but not in other test groups. When blood pressure was decreased to 50-60 torr CBF 
Discussion
Chronic hypertension produces a shift in cerebral autoregulation that impairs the ability of these subjects to maintain cerebral perfusion and oxygenation during hypotensive stimuli. [1] [2] [3] In normotensive subjects the lower limit of cerebral autoregulation has been report ed by Lassen 14 and Olessen et al. 15 to be between 60 and 70 torr. Below this limit oxygen extraction in creases to maintain CMR02 constant to an hypoxic limit of 40 to 50 torr. In hypertensive subjects Stran gaard et al. 16 reported a lower limit of cerebral autoreg ulation of approximately 120 torr and a hypoxic limit of 68 torr. Kety et al. 2 found a similar shift in cerebral autoregulation with signs of oxygen lack occuring above 100 mm Hg. In aged hypertensive patients, signs of cerebral ischemia have been reported at nor motensive levels. 1 A shift in cerebral autoregulation also occurs in SHR in response to hypotensive stimuli such as hemorrhage, ganglionic blockade and sodium nitroprusside infusion. ' " In addition, these changes are increased as a function of aging. 10 -" Vascular hypertrophy occurs in response to the on set of hypertension. 17 These changes protect the vascu lar tissue from increased perfusion pressure but alter the ability of tissues such as the brain to maintain blood flow and oxygenation at low pressures. 2 This problem may be increased in aged subjects as collagen forma tion increases and elasticity decreases in vascular tis- sue. [6] [7] [8] [9] Lundgren et al. 18 and Weiss 19 reported that low ering the blood pressure of hypertensive rats will partially or totally reverse the hindlimb vascular changes produced by the hypertension and improve the perfusion parameters of this tissue. Warshaw et al. 20 reported that 23 weeks of antihypertensive drug ther apy lowered resistance vessel smooth muscle cell con tent in SHR in direct proportion to the reduction in blood pressure. Strangaard 21 indicted that hypertensive subjects receiving antihypertensive therapy had a sig nificantly better cerebrovascular response to hypoten sive challenges than untreated hypertensives. Data presented here agree with these previous results and indicate that cerebral autoregulation and maintenance of cerebral metabolism during hemorrhage induced hypotension can be improved by 10 weeks of antihy pertensive therapy in aged SHR.
CBF was measured in these experiments for whole brain while brain venous samples were obtained from the sagittal sinus, which drains cerebral cortical re gions primarily. CMR02 values produced in these ex periments are probably somewhat higher than whole brain CMR02 because of the source of cerebral venous blood. However, since all treatment groups were test ed under the same conditions, this would not affect observed diffrences between treatment groups or test conditions. Antihypertensive drug treatment, includ ing the vasodilators minoxidil and hydralazine and the ^-adrenergic antagonist, propranolol, produced a sig nificant decrease in CMR02 but not CBF in both SHR and WKY under control anesthetized conditions, com pared to sham treated rats. We have observed similar results in young SHR and WKY using a similar drug treatment (unpublished results). Propranolol may be primarily responsible for these changes. Previously it has been reported that central /3-adrenergic simulation, produced by the sympathetic nervous system, may produce an increase in CMR02. 21 This effect was blocked by propranolol pretreatment. In addition, pro pranolol produced an approximate 20% decrease in basal CMR02. A similar effect of propranolol treat ment on basal CMR02 may have been present in these experiments. This effect apparently produced little change in cerebrovascular responsiveness since cere bral autoregulation was similar between sham and drug treated WKY.
One question concerning these studies is the ability of aged SHR to model the cerebrovascular changes seen in man. Although several factors are similar with respect to aged SHR and man, including arterial inti mal fibrinohyalin incorporation and decreased disten sibility of the brain vasculature with aging, 6-8 aged SHR do not develop arteriosclerosis. 9 This factor may be of importance, depending on its development in the small resistance vessels of the brain which are primar ily responsible for decreasing resistance during de creases in cerebral perfusion pressure. Other factors, however, such a hypertension induced vascular le sions 6 and decreased elasticity of cerebral resistance vessels are not a major hindrance to improvement of cerebrovascular performance following antihyperten sive therapy, as shown by these results.
